Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 671-680 of 1760 for

Edit search filters
  1. A Study Of Unesbulin Combined With Dacarbazine To Treat Advanced Leiomyosarcoma (LMS)

    Jacksonville, FL

  2. IL-2 Plus FOLFOX And Nivolumab For Treatment Of Peritoneal Metastases

    Rochester, MN

  3. Family Cancer Literacy to Promote Mammography Screening among Navajo Women

    Rochester, MN

  4. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  5. A Study To Test The Addition Of Berzosertib To Usual Radiation Treatment For Chemotherapy-Resistant Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate Radiotherapy To The Whole Breast Or Post-mastectomy Chest Wall Including Regional Nodal Irradiation

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate Abemaciclib For Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. De-Escalation Of Breast Radiation Trial For Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than Or Equal To 18 Breast Cancer (DEBRA)

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  9. Study Comparing Thin Dressings To Prevent Skin Inflammation In Breast Cancer Patients

    Rochester, MN

  10. Avelumab With Binimetinib, Sacituzumab Govitecan, Or Liposomal Doxorubicin In Treating Patients With Stage IV Or Unresectable, Recurrent Triple Negative Breast Cancer

    Rochester, MN

.

Mayo Clinic Footer